Mission: To bring nanotechnologies to the clinic

Medical Focus Areas: Cancer; Cardiovascular Medicine; Infectious Diseases; Diabetes

Strategic Emphasis: Early Detection of Disease from Blood Proteomic Signatures; Injectable NanoVectors for Directed (Targeted/personalized) Therapeutics; Intelligent Implants for Controlled Time Release of Therapy

Fundamental Platforms: Silicon/Semiconductors Nano/Microfabrication; Mathematics; Molecular Medicine; Pharmaceutical Science

Principal Funding: National Cancer Institute, National Institutes of Health, NASA, Department of Defense, National Science Foundation, State of Texas, State of Ohio.   

PRINCIPAL R&D PROGRAMS

• Early Detection of Disease from Blood Proteomic Signatures
• Injectable NanoVectors for Directed (Targeted/Personalized) Therapy 
• Intelligent Implants for Controlled Time Release of Therapy
• BioNanoScaffolds for Post-Traumatic OsteoRegeneration